We propose that serum GDNF levels may serve as a potential biological marker for the early prediction of brain white matter changes in PD-MCI patients, providing a convenient, non-invasive, and cost-effective tool for the early screening of Parkinson’s disease. The gene discussed is GDNF; the disease is Parkinson disease.